Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenetic Testing of Patients With Unwanted Adverse Drug Reactions or Therapy Failure

NCT04154553 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.

NCT NCT04154553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04154553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenetic Testing of Patients With Unwanted Adverse Drug Reactions or Therapy Failure
Lead sponsor
University Hospital, Basel, Switzerland
Phase
Observational
Overall status
Recruiting
Start date
October 15, 2019
Completion date
August 31, 2026
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug reaction, therapy failure